Back to Main

Faculty Detail    
Campus Address ACC 512 Zip 1711
Phone  (205) 638-9285
Other websites

Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Pediatrics   Ped - Hematology/Oncology Associate Professor
Center  General Clinical Research Center  Nephrology Research & Training Center Associate Professor

Biographical Sketch 
Education and Training 1993-1997 University of Pennsylvania Bachelor of Arts. Major in Biological Basis of Behavior with concentration in Neuroscience and Behavioral Medicine 1999-2003 Nova Southeastern University College of Osteopathic Medicine Doctor of Osteopathy. Graduated with Honors 2003-2004 Arnold Palmer Children’s Hospital for Women and Children. Intern. 2004-2006 Arnold Palmer Children’s Hospital for Women and Children. Pediatric Resident. 2006-2009 St. Jude Children’s Research Hospital. Fellowship in Pediatric Hematology Oncology. 2010 University of Alabama at Birmigham. Clinical and Translational Science Training Program 2010 American Society of Hematology Clinical Research Training Institute 2011-University of Alabama at Birmingham, School of Public Health, Masters of Science in Public Health, Clinical and Translational Science

Research/Clinical Interest
Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children's Research Hospital. His primary focus involves children with disorders of the blood, especially sickle cell Disease, thalassemia, disorders of iron metabolism, and marrow failure syndromes including aplastic anemia. His research focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. A long term goal of the research is gene therapy for blood disorders.

Selected Publications 
Publication PUBMEDID
Barriers in transition from pediatrics to adult medicine in sickle cell anemia.

Lebensburger JD, Bemrich-Stolz CJ, Howard TH.

Hydroxyurea treatment of children with hemoglobin SC disease.

Yates AM, Dedeken L, Smeltzer MP, Lebensburger JD, Wang WC, Robitaille N 
Impact of hydroxyurea on clinical events in the BABY HUG trial.

Thornburg CD, Files BA, Luo Z, Miller ST, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, Ware RE, Wang WC.

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.

Lebensburger JD, Miller ST, Howard TH, Casella JF, Brown RC, Lu M, Iyer RV, Sarnaik S, Rogers ZR, Wang WC; BABY HUG Investigators.

What is the evidence for using hydroxyurea for secondary stroke prevention?

Lebensburger JD, DeBaun MR, Thompson AA 
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin.

Lebensburger JD, Howard T, Hu Y, Pestina TI, Gao G, Johnson M, Zakharenko SS, Ware RE, Tuomanen EI, Persons DA, Rosch JW.

Laboratory and clinical correlates for magnetic resonance imaging (MRI) abnormalities in pediatric sickle cell anemia.

Lebensburger JD, Hilliard LM, McGrath TM, Fineberg NS, Howard TH.

Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.

Lebensburger J, Johnson SM, Askenazi DJ, Rozario NL, Howard TH, Hilliard LM.

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.

Lebensburger JD, Pestina TI, Ware RE, Boyd KL, Persons DA.

Bronchioloalveolar carcinoma as a second malignancy in osteosarcoma survivors.

Lebensburger J, Katzenstein H, Jenkins JJ, Rodriguez-Galindo C.

Biloma and pneumobilia in sickle cell disease.

Lebensburger J, Esbenshade A, Blakely M, Hankins J, Wang W.

Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.

Lebensburger J, Persons DA.